Improved Outcome of Septic Shock Patients Treated Without Polymyxin B Hemoperfusion

Nihon Kyukyu Igakukai Zasshi
doi 10.3893/jjaam.23.92
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Association for Acute Medicine

Related search

Polymyxin B Hemoperfusion in High Endotoxin Activity Level Septic Shock Patients

Critical Care
Critical CareIntensive Care Medicine
2008English

Re-Evaluation of Direct Hemoperfusion With Polymyxin-B Immobilized Fiber for Severe Sepsis and Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2011English

Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients With Septic Shock

Journal of Nippon Medical School
Medicine
2018English

Endotoxin Removal by Hemoperfusion in Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2011English

Correction To: Polymyxin B-Immobilized Hemoperfusion and Mortality in Critically Ill Adult Patients With Sepsis/Septic Shock: A Systematic Review With Meta-Analysis and Trial Sequential Analysis

Intensive Care Medicine
Critical CareIntensive Care Medicine
2018English

The Effect of Endotoxin Adsorber Hemoperfusion on Microcirculation in Patients With Severe Sepsis and Septic Shock

Intensive Care Medicine Experimental
Critical CareIntensive Care Medicine
2015English

Outcome Research in Meningococcal Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2008English

Does Etomidate Affect Prognosis in Septic Shock Patients Treated With Hydrocortisone?

Critical Care
Critical CareIntensive Care Medicine
2010English

Serum Lactate Level as a Predictor of Outcome in Patients With Septic Shock

Journal of BP Koirala Institute of Health Sciences
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy